Clinical Trial Update: Efficacy and Safety of GWP42003-P Oral Solution in Children With Epilepsy With Myoclonic-atonic Seizures [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating GWP42003-P oral solution for epilepsy with myoclonic-atonic seizures in children was terminated, with efficacy and safety results poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy with Myoclonic-atonic Seizures

Drugs mentioned

• GWP42003-P Oral Solution (cannabidiol)

Snippet

Sponsor: Jazz Pharmaceuticals | Conditions: Seizures Associated With EMAS | Phase 3 | Status: TERMINATED | Results posted: 2025-02-03